Softwr

Research · head to head

Greenphire vs Suzy

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
Suzy logo

Suzy

Research

Enterprise consumer insights on an owned US panel, resold elsewhere through Cint

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; Suzy the proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • They diverge on capability: Greenphire covers ClinCard, Suzy covers Suzy Insights.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and Suzy actually diverge.

Attributes where Greenphire and Suzy differ
AttributeGreenphireSuzy

Identical on both: starting price (On request), pricing model (quote), free tier (No), platforms (Web, iOS, Android), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in Suzy

  • Suzy Insights
  • Suzy Live
  • Suzy Audiences
  • Suzy Speaks
  • Video open ends
  • Advanced methods
  • Data Explorer
  • AI Decision Engine

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot Suzy
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot Suzy
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot Suzy
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot Suzy

Suzy

  • A US consumer packaged goods brand that needs concept testing back the same day because a packaging decision is due at the end of the week.not Greenphire
  • An insights department running an always-on brand tracker on a US audience without re-commissioning fieldwork every wave.not Greenphire
  • A team that wants quant screening followed immediately by moderated qual with the same respondents, rather than two vendors and two timelines.not Greenphire
  • A product team testing claims and price sensitivity with MaxDiff and conjoint on a panel they can go back to repeatedly.not Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

Suzy

  • The proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
  • Customers have asked Suzy to build proprietary panels with native speakers in Germany, France, Japan, India and Brazil, which confirms those do not exist today; multi-market brands need a second vendor and lose the single-source comparison.
  • Reviewers report the panel skews female and millennial and falls short on Gen Z, male and various ethnic segments, and that niche or B2B audiences are hard to reach, so quota fills can be slow or impossible.
  • Reviewers also raise data trust concerns about respondent sourcing and vetting, including one naming bot responses and acquiescence bias, which is the standing risk of any single owned opt-in panel with repeat respondents.
  • Pricing is a sales-led annual commitment reported to run around $88,000 a year at the median with onboarding fees and per-seat charges on top, with no trial, no self-serve and no pay-per-response option, so there is no cheap way to validate fit.
  • Credits are pre-committed monthly against forecast activity with no published overage rate, so under-use is wasted spend and a busy quarter triggers an unbudgeted purchase.
  • Integrations are genuinely thin: there is no public integrations page and no public API documentation, and the only confirmed external data relationship is Cint, so expect to move data by export.

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

Suzy

On request
  • Suzy$undefined/year
    • Annual subscription with pre-committed monthly research credits
    • Credit volume set against forecast study activity
    • Onboarding fees and per-seat charges quoted separately

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose Suzy if

  • You need suzy insights.
  • You work on Web, iOS, Android.
  • You also want suzy live.
Suzy review

Questions people ask

Is Greenphire or Suzy better?
Neither clearly leads. Greenphire starts at On request and Suzy at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or Suzy?
Greenphire starts at On request and Suzy at On request.
Does Greenphire or Suzy run on more platforms?
Both run on Web, iOS, Android, so platform support will not decide this one for you.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what Suzy is typically brought in for.
What can Greenphire do that Suzy cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. Suzy covers Suzy Insights, Suzy Live, Suzy Audiences, Suzy Speaks.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

Suzy: Is the panel global?

No. Crowdtap, the owned panel, is US only. International studies run on Cint supply, which you could contract for directly.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

Suzy: What does it cost?

Nothing is published. Third-party analysis puts the median contract around $88,000 a year with a range roughly $34,000 to $187,500, plus onboarding and per-seat fees.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

Suzy: Is there an API?

Nothing public. Suzy publishes no API documentation and no named connectors beyond Cint. Verify any integration requirement in the sales call before committing.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

Suzy: What changed in April 2026?

Suzy repositioned as an AI Decision Engine with Intelligence and Impact modules, while headcount fell from about 230 to 186. Ask how the roadmap is now split between that and the classic survey and qual products.

Share

Related pages

More on Greenphire

More on Suzy

Keep looking

Other head to heads